Ocular infection of guinea pigs with the guinea pig inclusion conjunctivitis (GPIC) strain of Chlamydia psittaci produces a clinical condition representative of acute chlamydial conjunctivitis in humans. Guinea pigs which had recovered from two challenges with GPIC were used as a source of sera for the identification of antigens present in GPIC-infected tissue culture cells but absent in the infectious elementary body (EB). Immunoblots of lysates of infected HeLa cells probed with the convalescent-phase sera identified protein antigens of 22, 34, and 52 kDa (p22, p34, and p52, respectively) that were not detected in lysates of purified EB or in uninfected HeLa cells. Protein p22 was also not detected in lysates of purified reticulate bodies.
Immunoblotting of lysates of HeLa cells infected with other chlamydiae demonstrated that the antigenicity of p22 and p34 was subspecies specific. Immunoblotting was also used to detect p22 and p34 in lysates of the conjunctivae of infected guinea pigs. Adsorption of convalescent-phase sera with GPIC EB produced a reagent with dominant reactivity toward p22, p34, and a 28-kDa EB protein. Immunofluorescent staining of GPIC-infected HeLa cells demonstrated that these adsorbed sera labeled the inclusion and inclusion membrane, with no apparent reactivity toward EB or reticulate bodies. Collectively, these data identify non-EB chlamydial components which may be released into the inclusion during intracellular growth.
Chlamydiae are obligate intracellular pathogens with a life cycle unique among prokaryotes (19) . Infection of target cells is mediated through a nonmetabolic life stage, the elementary body (EB), while intracellular multiplication progresses through the reticulate body (RB), a metabolically active, noninfectious form. After EB attachment and entry, chlamydiae remain separated from the cytoplasm in a membrane-bound vesicle, which grows in size until cell lysis and bacterial release. Fusion of the vesicle with host cell lysosomes is specifically inhibited during infection by chlamydiae (9, 10) . The inhibition of phagolysosomal fusion protects the invading bacterium from intracellular bacteriocidal mechanisms, but organisms sequestered within the vacuole are physically separated from cytoplasmic energy sources and anabolic precursors. Therefore, the inclusion membrane must be modified for the inhibition of phagolysosomal fusion and be selectively permeable to allow the intake of nutrients required for growth. No mechanisms for the directed modification of the inclusion membrane have been put forth, nor have any chlamydial components which function in this process been identified.
Many diverse facultative intracellular bacteria have recently been shown to synthesize proteins which facilitate the entry into and survival and multiplication inside target host cells. In some model systems, including Listeria, Salmonella, and Yersinia spp., the production of these components is upregulated under conditions which model the intracellular environment (16, 25) . Investigations directed at these environmentally regulated proteins have led to a better understanding of host-pathogen interactions in these systems, and have identified novel vaccine candidate antigens (4, 12) . Chlamydia spp. may also produce proteins which are present only within infected cells. One approach to identifying such proteins is to examine the spectrum of chlamydial antigens present within infected cells and compare this pattern with those only present in purified EBs. We used sera from guinea pigs that have recovered from acute conjunctivitis caused by the guinea pig inclusion conjunctivitis (GPIC) strain of Chlamydiapsittaci to demonstrate antigenic chlamydial proteins which are produced during in vitro and in vivo infections and are absent in the purified EB. Three such molecules were identified, one of which was detected only in the infected cell, and not in the EB or RB. Additionally, these sera were adsorbed with EBs and then used to demonstrate that chlamydial antigens can be localized to the inclusion membrane of infected cells.
MATERUILS AND METHODS
Chlamydial strains and culture conditions. EBs of C. psittaci GPIC, feline pneumonitis (Fel), ornithosis CP-3 (Orn), and meningopneumonitis (Mn); Chlamydia trachomatis serovars A/Har-13, D/UW-3, F/IC-Cal-3, and L2-434; and C. trachomatis MoPn/Weiss (MoPn) were purified from infected HeLa cell monolayers with serial Renografin (Squibb Diagnostics, New Brunswick, N.J.) gradients, and stored at -70°C (6 were generally consistent with other published results (17, 29, 31) .
Characterization of infection-specific chlamydial proteins produced in vitro and in vivo. Immunoblots of lysates of GPIC EBs and GPIC-infected cells demonstrated that convalescent sera recognized a spectrum of chlamydial components common to both EBs and infected HeLa cells, including the 60-kDa protein antigens (HSP 60, OMP 2), MOMP, a 28-kDa EB protein (p28), and lipopolysaccharide (LPS). However, antigenic bands which were not detected in the EBs were present in the infected cells (Fig. 1A) . Lysates of infected cells had three additional components, at relative molecular masses of 22, 34, and 52 kDa (p22, p34, and p52, respectively). Approximately 90% of guinea pigs which had recovered from two episodes of chlamydial conjunctivitis produced detectable antibodies reacting with p22 and p34 in immunoblots, while approximately 50% of the convalescent sera reacted with p52 (not shown). Immunoblots of lysates of uninfected cells were uniformly negative (Fig. 1A) . Protein p22 was absent in lysates of purified GPIC RBs while p34 was detected at relatively reduced concentrations (Fig. 1B) . Each of these antigens was shown to be proteinaceous, as LPS--*I their antigenicity was eliminated with proteinase K (Fig.  1C) .
Antisera produced in animals immunized systemically with live or formalin-fixed EBs were compared with the convalescent sera. Equal amounts of bacteria and identical immunization schedules were used in the preparation of antisera to fixed and viable EBs. Immunoblotting with these sera demonstrated that each reacted with a common set of EB components, but antisera prepared against viable EBs also reacted with p22, p34, and p52 (Fig. 2) . The pattern of reactivity with the antisera prepared against viable EBs was similar to that seen with the convalescent sera.
Immunoblotting of lysates of GPIC-infected conjunctivae demonstrated that the infection-specific proteins were detected on day 7 postchallenge (Fig. 3) . The pattern observed in infected animals is similar to that seen in infected cells.
MOMP, antigens at 60 kDa, and p28 were easily detected, and p22 and p34 were detected in infected conjunctivae with extended autoradiographic exposure times. (Fig. 4) Immunoblotting with adsorbed convalescent sera. Antibody reactivity specific for EB components was removed from convalescent sera by adsorption with EB extracts (Fig. 5) . This adsorption procedure produced a reagent with minimal reactivity toward all EB proteins and LPS, with the exception of p28. Antibody reactivity directed at p22 and p34 was unaffected by these adsorptions.
Fluorescence microscopy. Adsorbed and mock-adsorbed convalescent sera and sera from animals immunized with formalin-fixed EBs were used to examine infected cells by fluorescence microscopy. Chlamydial developmental forms were the dominant feature in GPIC-infected HeLa cells which were probed with either antisera against fixed EBs (Fig. 6B) or the unadsorbed convalescent sera (not shown). However, staining with the adsorbed convalescent sera demonstrated a distinctly different pattern; the chlamydiae within the inclusion fluoresced very weakly, but other structures within the inclusion fluoresced strongly (Fig. 6D) . Staining was intense in the perinuclear center of the inclusion while staining in the periphery was associated with the margins of lobed structures which surrounded groups of individual chlamydiae. These lobes, or multiple inclusions, varied in size from approximately 2 to 6 ,um. The lobed structures shown in these micrographs are structurally consistent with published descriptions of the inclusion morphology observed with GPIC-infected L cells (26 
DISCUSSION
We have identified three antigenic chlamydial proteins (p22, p34, and p52) that were present in infected cells but were not detected in purified EBs. The proteins p34 and p52 were each detected in RBs, while p22 was not detected in purified RBs. These three proteins were not recognized by guinea pigs systemically immunized with formalin-killed EB preparations, but were recognized by sera from guinea pigs ocularly infected or systemically immunized with live EBs. Therefore, an antibody response to p22, p134, and p52 was generated by either systemic or mucosal challenge with live organisms, indicating that immune recognition is likely dependent upon the growth of GPIC within infected host cells.
The described antigens were not detected in lysates of uninfected cycloheximide-treated HeLa cells, nor were they found in cycloheximide-treated cells infected with C. trachomatis. These results eliminated the possibility that these antigens are immunologically cross-reactive HeLa cell proteins produced during normal growth or under the stress of chlamydial infection.
Antibodies directed against certain chlamydial antigens were not consistently produced in convalescent guinea pigs, resulting in certain discrepancies between blots probed with different pools of convalescent sera. This is demonstrated in the blots shown in Fig. 1 . A protein at 45 kDa and the 52-kDa RB protein (p52) are differentially present and absent in these blots. These inconsistencies reflect differences in the sera used in the blots and not differences in the antigen preparations (not shown).
Immunoblots of selected strains of C. psittaci and C. trachomatis were performed to examine the distribution of the infection-specific antigens within members of the genus Chlamydia. There was no evidence of cross-reactivity with similar antigens in any of the tested C. trachomatis serovars, and the cross-reactivity with C. psittaci strains was limited: p34 has an apparent homolog in two of the three tested strains, while there was no evidence of antigenic crossreactivity with a homolog of p22. These results support the conclusion that the antigenicity of p22 and p34 is subspecies specific.
To our knowledge, this is the first description of chlamydial antigens not detected in purified EBs. In the guinea pig system, several authors have identified GPIC antigens which are recognized in the context of infection, but the antigens uniformly used in immunoblots were lysates of purified GPIC EBs (3, 22, 29) . Many approaches have been used to examine the antigenicity of MOMP, LPS, and the 60-kDa proteins (2, 30, 32; reviewed in reference 18), and additional EB antigens have been identified in surveys of the antibody response in infected humans and infected or immunized animals. These include a spectrum of different protein species and a genus-common glycolipid antigen, GLX A (7, 11, 13, 21, 23, 27) . While some of these antigens have been reported to be released from chlamydial developmental forms (15, 27, 28) , none were shown to be unique to infected cells.
Adsorption of convalescent sera with 2-mercaptoethanoltreated EBs yielded a reagent which did not react with LPS, MOMP, or other identified EB components. The adsorbed sera retained strong reactivity toward p22 and p34, and toward the 28-kDa EB protein. Because all reactivity with the dominant EB antigens was eliminated by these adsorptions, these results provide evidence that p22 and p34 are not breakdown products of previously identified higher-molecular-weight proteins. The adsorbed sera were also used in fluorescence microscopy of methanol-fixed infected HeLa cells. These sera reacted with antigens associated with the surface of the lobed inclusions and not with the developmental forms within each lobe. Essentially identical FA results were obtained with paraformaldehyde fixation of infected HeLa cells (not shown). The lobular nature of the inclusions presented in this report is similar to that described by Spears and Storz (26) , who developed a biotyping system for C. psittaci based on morphological differences of inclusions from different strains. The FA images obtained with the adsorbed sera resemble their micrographs for L cells infected with GPIC (biotype 8) and cells infected with strains from biotype 4. The FA staining pattern observed with the adsorbed INFECT. IMMUN. convalescent sera contrasted with the pattern seen with antisera raised against killed EBs (Fig. 6) , which predominantly recognized the developmental forms within the inclusion. Because the adsorbed sera recognized principally the three proteins of 22, 28, and 34 kDa in immunoblots, it is possible that one or more of these proteins is released from intracellular chlamydiae and is in contact with the inclusion membrane. However, it is clear from the immunoblot in Fig.  5 that other antigens (39, 60, and 100 kDa) are faintly recognized by these adsorbed sera. The production of monospecific antisera will be required to identify individual chlamydial proteins which are localized to the inclusion membrane of infected cells.
The biphasic growth cycle used by chlamydiae is unique among bacteria. However, a similar life cycle is carried out by Toxoplasma gondii, a protozoan parasite of humans and other animals (14) . A collection of Toxoplasma proteins (ROP 1, GRA 1 to 5) is released from the parasite upon infection, two of which are associated with the parasitophorous vacuolar membrane (1, 5, 8, 14, 20, 24) . It is proposed that these proteins are important in the modification of the intracellular environment for the benefit of the parasite. We anticipate that similar experimental approaches will facilitate the identification and characterization of individual chlamydial proteins which may function on or about the inclusion membrane.
This work was initiated to identify potentially important immunogens that may be present only during chlamydial infection. The rationale for this approach is that the most successful current technique for generating solid immunity to chlamydial infection is prior infection with a homologous strain or serovar (18) . The novel proteins described in this paper are subspecies-specific antigens only identified in infected cells in vivo and in vitro, characteristics which are consistent with the requirements for protective chlamydial antigens. Research addressing the roles of these proteins in the protective immune response is dependent on the production of preparative amounts of purified candidate proteins, and such efforts are in progress.
